Biotech News
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
investors.rxsight.com2026-05-06 20:14 EST
ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026. Strategic Highlights and Recent Developments Q1 sales of $30.9 million driven by 27,472 Light Adjustable Lens (LAL) units 20 Light Delivery